Orion Corporation

Update in progress

ORNAV.HE (Helsinki)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Europe, North America, and globally. Its portfolio includes Nubeqa, Entacapone/Stalevo/Comtess/Comtan, Burana, Divina, Simdax, Fareston, Quetiapine products, Trexan, Easyhaler lines, and Dexdor, Dexmedetomidine. It also offers asthma/COPD inhalers, veterinary drugs, APIs, contract manufacturing, and self-care products online, with TNX-103 and darolutamide licenses. Founded 1917 in Espoo.

Company score

Sentiment: 0.13; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.26; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.19; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.12; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.12; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive